Skip to content
healthcare.dev

BIVALIRUDIN

NDC 55150-210, BIVALIRUDIN, injection, powder, lyophilized, for solution, from Eugia US LLC.

Product NDC
55150-210
Status
Listed
Labeler
Eugia US LLC
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205962
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55150-210 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BIVALIRUDIN250 mg/1

Pharmacologic classes

Anti-coagulant [EPC]; Direct Thrombin Inhibitor [EPC]; Thrombin Inhibitors [MoA]

Package NDCNDC-11Package
55150-210-105515002101010 VIAL, SINGLE-DOSE in 1 CARTON (55150-210-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e574d04f-67b4-4a84-9d66-8c2d54f95120
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=55150-210

Use it

Look up 55150-210 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55150-210 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55150-210. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.